
A new cancer hospital is scheduled to open in the Fall of 2009. The Smilow Cancer Hospital at Yale-New Haven is expected to be the most comprehensive cancer facility between New York and Boston.
Yale-New Haven's 14-story, 497,000 square-foot Smilow Cancer Hospital, now under construction at Park Street and South Frontage Road, will offer patients state-of-the-art care and treatment.
The 14 story hospital will have 112 patient beds, outpatient treatment rooms, expanded operating rooms, infusion suites, diagnostic imaging services and therapeutic radiology. Also planned is a specialized Women's Cancer Center which will be coordinated with the Yale-New Haven Breast Center/GYN Oncology Center. When the new center is open, all of Yale-New Haven Hospital’s cancer services will be housed in the new facility. Currently the cancer services at Yale New Haven Hospital are located in six different buildings.

The new cancer hospital is a partnership between Yale-New Haven Hospital, Yale School of Medicine and the Yale Cancer Center. Joel E. Smilow a Yale alumnus and former CEO and President of Playtex Products donated a major contribution in support of the cancer center. The center will be called the Smilow Cancer Hospital.
It is the intention of the new hospital to bring together the best minds at Yale New Haven Hospital, the medical school and the current Yale cancer center. The goal of this confluence of medical talent is to develop new methods of prevention as well as diagnosis and treatment of various cancers.
Yale Cancer Center is southern New England’s only comprehensive cancer center designated by the National Cancer Institute (NCI) and one of only 40 in the nation.
In addition to the medical facilities the new facility will research new drugs and treatments for specific forms of cancer. Twelve teams of specialists, each nationally recognized for pioneering work in specific forms of cancer will contribute their expertise to the new center.

Recognizing that patient’s needs go beyond just medical treatments, the center will have a roof top healing garden which cancer patients can go to relax, visit with family and refocus on life.
The Smilow Cancer Hospital that is be a part of New Haven’s Community Investment Program. This is in keeping with the city of New Haven’s request that new development projects also take into consideration the needs of the community in which it is built. Building trade workers will be from the New Haven community. New Haven residents will be employed by the center.
Thomas J. Lynch, Jr., MD, has been named director of Yale Cancer Center and physician-in-chief of the new Smilow Cancer Hospital at Yale-New Haven. His appointment was effective April 1, 2009.
Dr. Lynch was a professor of medicine at Harvard Medical School. He was also chief of hematology/oncology at Massachusetts General Hospital (MGH) Cancer Center. A lung cancer expert, he was also a director of the Center for Thoracic Cancers at MGH and a director of medical oncology at the MGH Thoracic Oncology Center.